Popular Keywords

Vaccine Development & Technologies

mRNA vaccines

DNA vaccines

Recombinant vaccines

Viral vector vaccines

Live attenuated vaccines

Editor-in-Chief

Seyed Mehrdad Mirsalami

Seyed Mehrdad Mirsalami
Editor-in-Chief
Department of Medicine
Central Tehran University,iran

Biography

Seyed Mehrdad Mirsalami is currently working as an Assistant Professor at the Central Tehran University at Tehran. He graduated from the Central Tehran University in Iran
 

Research Interest

His area of interest is in mRNA Vaccine Development, DNA Vaccines, Recombinant Protein Vaccines, Viral Vector Vaccines, Live Attenuated Vaccines, Nanoparticle Vaccines, Adjuvant Development – TLR agonists, cytokine adjuvants, and novel immunostimulants, Computational Vaccinology, Immunoinformatics – Bioinformatics tools for B-cell and T-cell epitope mapping, CRISPR-Based Vaccine Design, Next-Generation Delivery Systems, Mucosal Immunity, T-Cell & B-Cell Immunology, Single-Cell Transcriptomics, Biomanufacturing & Scale-Up

Journal Info

  • Journal Name: Advances in Vaccines
  • ISSN: 3068-3734
  • DOI: 10.52338/aiv
  • Short Name: AIV
  • Acceptance rate: 75%
  • Volume: 1 (2025)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility